Survival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFκB survival axis downstream of Death receptor-3

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Porquet, Nicolas ^a,b   Poirier, Andrée ^a   Houle, François ^a   Pin, Anne Laure ^a   Gout, Stéphanie ^a,c   Tremblay, Pierre Luc ^a,d   Paquet, Éric R ^a   Klinck, Roscoe ^e   Auger, François A ^d   Huot, Jacques ^a  

^a University Laval   (Canada)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c INSTITUT ALBERT BONNIOT   (France)

^d LAVAL UNIVERSITY   (Canada)

^e UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Colon cancer; Death receptor 3; E selectin; PI3 kinase; Splice variant

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CASPASE 3; CASPASE 8; DEATH RECEPTOR 3; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELA; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; CHROMONE DERIVATIVE; ISOPROTEIN; MORPHOLINE DERIVATIVE; PROTEIN TYROSINE KINASE; SELE PROTEIN, HUMAN; TNFRSF25 PROTEIN, HUMAN;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CAPILLARY ELECTROPHORESIS; CELL INTERACTION; CELL SURVIVAL; COLON CANCER; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; MICROCIRCULATION; POLYMERASE CHAIN REACTION; PROTEIN CLEAVAGE; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; CELL ADHESION; CELL STRAIN HT29; CHEMISTRY; COLON TUMOR; FLUORESCENCE MICROSCOPY; GENETICS; LEUKEMIA CELL LINE; METABOLISM; METASTASIS; MOLECULAR GENETICS; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; UMBILICAL VEIN ENDOTHELIAL CELL;

AMINO ACID SEQUENCE; APOPTOSIS; CELL ADHESION; CELL SURVIVAL; CHROMONES; COLONIC NEOPLASMS; E-SELECTIN; HT29 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; JURKAT CELLS; MAP KINASE SIGNALING SYSTEM; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; MORPHOLINES; NEOPLASM METASTASIS; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 25; SRC-FAMILY KINASES;

EID: 79959758109     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-285     Document Type: Article

References (54)

1. Gout S, Tremblay PL, Huot J. Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis. Clin Exp Metastasis 2008, 25(4):335-344. 10.1007/s10585-007-9096-4, 17891461.
2. Gout S, Huot J. Role of cancer microenvironment in metastasis: Focus on colon cancer. Cancer Microenvironment 2008, 1(1):69-83. 10.1007/s12307-008-0007-2, 2654352, 19308686.
3. Porquet N, Gout S, Huot J. The metastatic process: an overview. in Metastasis of colorectal cancer. Cancer Metastasis-Biology and Treatment 2010, 14:1-31. Springer.
4. Wiese G, Barthel SR, Dimitroff CJ. Analysis of physiologic E-selectin-mediated leukocyte rolling on microvascular endothelium. J Vis Exp 2009, (24).
5. Woodward J. Crossing the endothelium: E-selectin regulates tumor cell migration under flow conditions. Cell Adh Migr 2008, 2(3):151-152. 10.4161/cam.2.3.6820, 2634092, 19262108.
6. Kobayashi H, Boelte KC, Lin PC. Endothelial cell adhesion molecules and cancer progression. Curr Med Chem 2007, 14(4):377-386. 10.2174/092986707779941032, 17305540.
7. Burdick MM, McCaffery JM, Kim YS, Bochner BS, Konstantopoulos K. Colon carcinoma cell glycolipids, integrins, and other glycoproteins mediate adhesion to HUVECs under flow. Am J Physiol Cell Physiol 2003, 284(4):C977-987.
8. Tozeren A, Kleinman HK, Grant DS, Morales D, Mercurio AM, Byers SW. E-selectin-mediated dynamic interactions of breast- and colon-cancer cells with endothelial-cell monolayers. Int J Cancer 1995, 60(3):426-431.
9. Tremblay PL, Huot J, Auger FA. Mechanisms by which E-selectin regulates diapedesis of colon cancer cells under flow conditions. Cancer Res 2008, 68(13):5167-5176. 10.1158/0008-5472.CAN-08-1229, 18593916.
10. Sawada R, Tsuboi S, Fukuda M. Differential E-selectin-dependent adhesion efficiency in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem 1994, 269(2):1425-1431.
11. Khatib AM, Fallavollita L, Wancewicz EV, Monia BP, Brodt P. Inhibition of hepatic endothelial E-selectin expression by C-raf antisense oligonucleotides blocks colorectal carcinoma liver metastasis. Cancer Res 2002, 62(19):5393-5398.
12. Brodt P, Fallavollita L, Bresalier RS, Meterissian S, Norton CR, Wolitzky BA. Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis. Int J Cancer 1997, 71(4):612-619. 10.1002/(SICI)1097-0215(19970516)71:4<612::AID-IJC17>3.0.CO;2-D, 9178816.
13. Kobayashi K, Matsumoto S, Morishima T, Kawabe T, Okamoto T. Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression. Cancer Res 2000, 60(14):3978-3984.
14. Kannagi R. Carbohydrate antigen sialyl Lewis a--its pathophysiological significance and induction mechanism in cancer progression. Chang Gung Med J 2007, 30(3):189-209.
15. Thomas SN, Schnaar RL, Konstantopoulos K. Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells. Am J Physiol Cell Physiol 2009, 296(3):C505-513. 2660269, 19118161.
16. Hanley WD, Burdick MM, Konstantopoulos K, Sackstein R. CD44 on LS174T colon carcinoma cells possesses E-selectin ligand activity. Cancer Res 2005, 65(13):5812-5817. 10.1158/0008-5472.CAN-04-4557, 15994957.
17. Tomlinson J, Wang JL, Barsky SH, Lee MC, Bischoff J, Nguyen M. Human colon cancer cells express multiple glycoprotein ligands for E-selectin. Int J Oncol 2000, 16(2):347-353.
18. Thomas SN, Zhu F, Schnaar RL, Alves CS, Konstantopoulos K. Carcinoembryonic antigen and CD44 variant isoforms cooperate to mediate colon carcinoma cell adhesion to E- and L-selectin in shear flow. J Biol Chem 2008, 283(23):15647-15655. 10.1074/jbc.M800543200, 2414264, 18375392.
19. Zen K, Liu DQ, Guo YL, Wang C, Shan J, Fang M, Zhang CY, Liu Y. CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration. PLoS ONE 2008, 3(3):e1826. 10.1371/journal.pone.0001826, 2265551, 18350162.
20. Laferriere J, Houle F, Taher MM, Valerie K, Huot J. Transendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells. J Biol Chem 2001, 276(36):33762-33772. 10.1074/jbc.M008564200, 11448946.
21. D'Amato M, Flugy AM, Alaimo G, Bauder B, Kohn EC, De Leo G, Alessandro R. Role of calcium in E-selectin induced phenotype of T84 colon carcinoma cells. Biochem Biophys Res Commun 2003, 301(4):907-914. 10.1016/S0006-291X(03)00062-7, 12589798.
22. Soltesz SA, Powers EA, Geng JG, Fisher C. Adhesion of HT-29 colon carcinoma cells to E-selectin results in increased tyrosine phosphorylation and decreased activity of c-src. Int J Cancer 1997, 71(4):645-653. 10.1002/(SICI)1097-0215(19970516)71:4<645::AID-IJC22>3.0.CO;2-9, 9178821.
23. Gout S, Morin C, Houle F, Huot J. Death receptor-3, a new E-Selectin counter-receptor that confers migration and survival advantages to colon carcinoma cells by triggering p38 and ERK MAPK activation. Cancer Res 2006, 66(18):9117-9124. 10.1158/0008-5472.CAN-05-4605, 16982754.
24. Debatin KM, Krammer PH. Death receptors in chemotherapy and cancer. Oncogene 2004, 23(16):2950-2966. 10.1038/sj.onc.1207558, 15077156.
25. Muppidi JR, Tschopp J, Siegel RM. Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction. Immunity 2004, 21(4):461-465. 10.1016/j.immuni.2004.10.001, 15485624.
26. Sancho-Martinez I, Martin-Villalba A. Tyrosine phosphorylation and CD95: a FAScinating switch. Cell Cycle 2009, 8(6):838-842. 10.4161/cc.8.6.7906, 19221505.
27. Screaton GR, Xu XN, Olsen AL, Cowper AE, Tan R, McMichael AJ, Bell JI. LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc Natl Acad Sci USA 1997, 94(9):4615-4619. 10.1073/pnas.94.9.4615, 20772, 9114039.
28. Warzocha K, Ribeiro P, Charlot C, Renard N, Coiffier B, Salles G. A new death receptor 3 isoform: expression in human lymphoid cell lines and non-Hodgkin's lymphomas. Biochem Biophys Res Commun 1998, 242(2):376-379. 10.1006/bbrc.1997.7948, 9446802.
29. Bodmer JL, Burns K, Schneider P, Hofmann K, Steiner V, Thome M, Bornand T, Hahne M, Schroter M, Becker K, Wilson A, French LE, Browning JL, MacDonald HR, Tschopp J. TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity 1997, 6(1):79-88. 10.1016/S1074-7613(00)80244-7, 9052839.
30. Marsters SA, Sheridan JP, Donahue CJ, Pitti RM, Gray CL, Goddard AD, Bauer KD, Ashkenazi A. Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-kappa B. Curr Biol 1996, 6(12):1669-1676. 10.1016/S0960-9822(02)70791-4, 8994832.
31. Wen L, Zhuang L, Luo X, Wei P. TL1A-induced NF-kappaB activation and c-IAP2 production prevent DR3-mediated apoptosis in TF-1 cells. J Biol Chem 2003, 278(40):39251-39258. 10.1074/jbc.M305833200, 12882979.
32. Migone TS, Zhang J, Luo X, Zhuang L, Chen C, Hu B, Hong JS, Perry JW, Chen SF, Zhou JX, Cho YH, Ullrich S, Kanakaraj P, Carrell J, Boyd E, Olsen HS, Hu G, Pukac L, Liu D, Ni J, Kim S, Gentz R, Feng P, Moore PA, Ruben SM, Wei P. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 2002, 16(3):479-492. 10.1016/S1074-7613(02)00283-2, 11911831.
33. Escaffit F, Perreault N, Jean D, Francoeur C, Herring E, Rancourt C, Rivard N, Vachon PH, Pare F, Boucher MP, Auclair J, Beaulieu JF. Repressed E-cadherin expression in the lower crypt of human small intestine: a cell marker of functional relevance. Exp Cell Res 2005, 302(2):206-220. 10.1016/j.yexcr.2004.08.033, 15561102.
34. Huot J, Houle F, Marceau F, Landry J. Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ Res 1997, 80(3):383-392.
35. Lee YK, Park SY, Kim YM, Park OJ. Regulatory effect of the AMPK-COX-2 signaling pathway in curcumin-induced apoptosis in HT-29 colon cancer cells. Ann N Y Acad Sci 2009, 1171:489-494. 10.1111/j.1749-6632.2009.04699.x, 19723094.
36. Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 1991, 19(9):2499. 10.1093/nar/19.9.2499, 329467, 2041787.
37. Klinck R, Bramard A, Inkel L, Dufresne-Martin G, Gervais-Bird J, Madden R, Paquet ER, Koh C, Venables JP, Prinos P, Jilaveanu-Pelmus M, Wellinger R, Rancourt C, Chabot B, Abou Elela S. Multiple alternative splicing markers for ovarian cancer. Cancer Res 2008, 68(3):657-663. 10.1158/0008-5472.CAN-07-2580, 18245464.
38. Tremblay PL, Auger FA, Huot J. Regulation of transendothelial migration of colon cancer cells by E-selectin-mediated activation of p38 and ERK MAP kinases. Oncogene 2006, 25(50):6563-6573. 10.1038/sj.onc.1209664, 16715142.
39. Weis S, Cui J, Barnes L, Cheresh D. Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J Cell Biol 2004, 167(2):223-229. 10.1083/jcb.200408130, 2172541, 15504909.
40. Weis S, Shintani S, Weber A, Kirchmair R, Wood M, Cravens A, McSharry H, Iwakura A, Yoon YS, Himes N, Burstein D, Doukas J, Soll R, Losordo D, Cheresh D. Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. J Clin Invest 2004, 113(6):885-894. 362122, 15067321.
41. Hu R, Kim BR, Chen C, Hebbar V, Kong AN. The roles of JNK and apoptotic signaling pathways in PEITC-mediated responses in human HT-29 colon adenocarcinoma cells. Carcinogenesis 2003, 24(8):1361-1367. 10.1093/carcin/bgg092, 12819185.
42. Mi L, Chung FL. Binding to protein by isothiocyanates: a potential mechanism for apoptosis induction in human non small lung cancer cells. Nutr Cancer 2008, 60(Suppl 1):12-20.
43. Chen J. The Src/PI3K/Akt pathway may play a key role in the production of IL-17 in obesity. J Leukoc Biol 87(3):355. author reply 357.
44. Sagan D, Eckardt-Schupp F, Eichholtz-Wirth H. Reduced expression of SRC family kinases decreases PI3K activity in NBS1-/- lymphoblasts. Biochem Biophys Res Commun 2008, 377(1):181-186. 10.1016/j.bbrc.2008.09.098, 18835245.
45. Lohi O, Lehto VP. ITAM motif in an apoptosis-receptor. Apoptosis 1998, 3(5):335-336. 10.1023/A:1009672903627, 14646480.
46. Engelman JA. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 2009, 9(8):550-562. 10.1038/nrc2664, 19629070.
47. Silverman N, Maniatis T. NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev 2001, 15(18):2321-2342. 10.1101/gad.909001, 11562344.
48. Su WB, Chang YH, Lin WW, Hsieh SL. Differential regulation of interleukin-8 gene transcription by death receptor 3 (DR3) and type I TNF receptor (TNFRI). Exp Cell Res 2006, 312(3):266-277.
49. Natoli G, Costanzo A, Guido F, Moretti F, Bernardo A, Burgio VL, Agresti C, Levrero M. Nuclear factor kB-independent cytoprotective pathways originating at tumor necrosis factor receptor-associated factor 2. J Biol Chem 1998, 273(47):31262-31272. 10.1074/jbc.273.47.31262, 9813034.
50. Gingery A, Bradley EW, Pederson L, Ruan M, Horwood NJ, Oursler MJ. TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival. Exp Cell Res 2008, 314(15):2725-2738. 10.1016/j.yexcr.2008.06.006, 2578840, 18586026.
51. Ren M, Guan Q, Zhong X, Gong B, Sun Y, Xin W, Guo J, Wang H, Gao L, Zhao J. Phosphatidylinositol 3-kinase/nuclear factor-kappa B signaling pathway is involved in the regulation of IGF-I on Fas-associated death domain-like interleukin-1-converting enzyme-inhibitory protein expression in cultured FRTL thyroid cells. J Mol Endocrinol 2007, 38(6):619-625. 10.1677/JME-07-0020, 17556532.
52. Hayes GM, Carrigan PE, Miller LJ. Serine-arginine protein kinase 1 overexpression is associated with tumorigenic imbalance in mitogen-activated protein kinase pathways in breast, colonic, and pancreatic carcinomas. Cancer Res 2007, 67(5):2072-2080. 10.1158/0008-5472.CAN-06-2969, 17332336.
53. Patel NA, Chalfant CE, Watson JE, Wyatt JR, Dean NM, Eichler DC, Cooper DR. Insulin regulates alternative splicing of protein kinase C beta II through a phosphatidylinositol 3-kinase-dependent pathway involving the nuclear serine/arginine-rich splicing factor, SRp40, in skeletal muscle cells. J Biol Chem 2001, 276(25):22648-22654. 10.1074/jbc.M101260200, 11283022.
54. Ge ZJ, Sanders AJ, Ye L, Jiang WG. Aberrant expression and function of death receptor-3 and death decoy receptor-3 in human cancer. Exp Therap Med 2011, 2:167-172.